Regulating Reverse Payment Agreements in Pharmaceutical Market: A Comprehensive Framework for Antitrust Review
Reverse payment settlement agreement is a type of arrangement between original and generic drug manufacturers that could potentially violate Antitrust Laws by limiting competition, typically appear in the pharmaceutical market. This paper addresses the impact of these agreements on public interests,...
Main Author: | Yang Xupeng |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2023-01-01
|
Series: | SHS Web of Conferences |
Online Access: | https://www.shs-conferences.org/articles/shsconf/pdf/2023/27/shsconf_icprss2023_03010.pdf |
Similar Items
-
Antitrust, regulation, and competition /
by: Baldassarri, Mario, 1946-, et al.
Published: (2003) -
Market dominance and antitrust policy /
by: Utton, M. A. (Michael A.), 1939-
Published: (1995) -
Market dominance and antitrust policy /
by: Utton, M. A. (Michael A.), 1939-
Published: (2003) -
Private antitrust enforcement in digital market
by: Dominik Wolski
Published: (2020-12-01) -
ANTITRUST REGULATION OF THE ACTIVITIES OF INSURANCE COMPANIES
by: G. A. Nasyrova
Published: (2014-10-01)